Catalent CTS, LLC
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- United States
- Registered address
- 10245 Hickman Mills Dr, Kansas City, Missouri (MO) 64137, United States (USA)
- Operations here
- analysislabelmanufacturepack
- FDA identifiers
- FEI 3002929455 · DUNS 962674474
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- NAIDrug Quality Assurance2022-03-04
- NAIDrug Quality Assurance2017-11-06
- NAIDrug Quality Assurance2015-06-29
- VAIDrug Quality Assurance2014-11-10
- NAIDrug Quality Assurance2014-03-05
- NAIDrug Quality Assurance2013-01-14
- NAIDrug Quality Assurance2012-06-08
- VAIDrug Quality Assurance2010-03-24
Drugs this plant is listed as making
6 distinct drugs across 11 products name this site in their FDA label.
- Berotralstat hydrochlorideBioCryst Pharmaceuticals, Inc.
- cabozantinibExelixis, Inc.
- duvelisibSecura Bio, Inc
- gemcitabine intravesicalJanssen Biotech, Inc
- MaribavirTakeda Pharmaceuticals America, Inc.
- sparsentanTravere Therapeutics, Inc.
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.